Chembio Diagnostics (CEMI.Q) Begins Commercialization of Third-Party SCoV-2 Ag Detect™ Rapid Test
Chembio Diagnostics (CEMI.Q) today announced its launch of commercial distribution of an FDA Emergency Use Authorized, patent pending, rapid point-of-care COVID-19 antigen test for use… Read More »Chembio Diagnostics (CEMI.Q) Begins Commercialization of Third-Party SCoV-2 Ag Detect™ Rapid Test





